STOCK TITAN

LMAT (NASDAQ) Form 144: Trent Kamke plans sale of 2,625 shares via option exercise

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

LMAT files a Form 144 to offer 2,625 shares of Common Stock for sale. The notice states the planned sale arises from a stock option exercise and is dated 03/11/2026.

The filing also records a prior sale of 1,044 shares on 02/27/2026 by Trent G. Kamke for $115,142.76.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does LMAT's Form 144 filed on 03/11/2026 report?

The Form 144 reports an intended sale of 2,625 shares of common stock tied to a stock option exercise dated 03/11/2026. It also lists a prior sale of 1,044 shares on 02/27/2026 that realized $115,142.76.

Who is the seller named in the LMAT Form 144?

The filing identifies Trent G. Kamke as a selling individual and shows previous activity by him. His recorded prior sale was 1,044 shares on 02/27/2026 for $115,142.76, per the notice.

How many shares does LMAT plan to sell under the Form 144 notice?

The notice indicates an intended sale of 2,625 shares of common stock associated with a stock option exercise, dated 03/11/2026. The sale method is listed as cash in the excerpt.

What recent sales does the LMAT filing disclose?

The filing discloses a prior sale of 1,044 shares on 02/27/2026 attributed to Trent G. Kamke, with proceeds of $115,142.76. The excerpt lists that past sale under "Securities Sold During The Past 3 Months."

Does the Form 144 specify how the shares will be sold for LMAT?

Yes; the excerpt describes the planned transaction as resulting from a stock option exercise and lists the method as cash. The filing date for that planned sale is 03/11/2026 as shown in the excerpt.
Lemaitre Vasculr

NASDAQ:LMAT

View LMAT Stock Overview

LMAT Rankings

LMAT Latest News

LMAT Latest SEC Filings

LMAT Stock Data

2.47B
20.80M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
BURLINGTON